4.6 Review

Autophagy Contributes to Metabolic Reprogramming and Therapeutic Resistance in Pancreatic Tumors

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Oncology

Genetic Mutations of Pancreatic Cancer and Genetically Engineered Mouse Models

Yuriko Saiki et al.

Summary: Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy and a major cause of cancer-related deaths worldwide. Recent multi-gene analysis methods have provided valuable insight into the molecular characteristics of pancreatic tumors, with different types of pancreatic cancer and precursor lesions showing specific molecular alterations. Genetically engineered mouse models (GEMMs) driven by oncogenic Kras have proven to be useful in understanding the roles of altered genes and recapitulating key features of human PDAC.

CANCERS (2022)

Review Oncology

Autophagy as a therapeutic target in pancreatic cancer

Max Piffoux et al.

Summary: PDAC is characterized by early metastasis and resistance to therapy, with mutations in KRAS and TP53 showing little clinical efficacy. Autophagy, upregulated in PDAC, plays a role in resistance to treatments, making it a potential therapeutic target. Combining inhibitors of the ERK/MAPK pathway with autophagy inhibitors has shown interesting results in PDAC models and other KRAS-driven cancers.

BRITISH JOURNAL OF CANCER (2021)

Review Cell Biology

Regulation and function of autophagy in pancreatic cancer

Jingbo Li et al.

Summary: Autophagy is a degradation system that can remove abnormal proteins and damaged organelles, with impaired autophagy being a pathological feature of diseases like pancreatic cancer. Dysfunctional autophagy plays a complex role in pancreatic tumor biology, with targeting selective autophagy potentially reducing side effects of drugs.

AUTOPHAGY (2021)

Article Oncology

Cancer Statistics, 2021

Rebecca L. Siegel et al.

Summary: Every year, the American Cancer Society projects the numbers of new cancer cases and deaths in the United States, with the latest data showing a significant decline in lung cancer mortality, while prostate cancer mortality has plateaued and breast and colorectal cancer mortality have slowed. Improvements in treatment have accelerated progress against lung cancer, leading to a record drop in overall cancer mortality.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Cell Biology

Functional Genomics In Vivo Reveal Metabolic Dependencies of Pancreatic Cancer Cells

Xiphias Ge Zhu et al.

Summary: This study reveals that loss of heme synthesis reduces tumor growth in PDAC, and autophagy plays a crucial role in immune evasion of pancreatic tumors.

CELL METABOLISM (2021)

Review Biochemistry & Molecular Biology

Targeting Redox Metabolism in Pancreatic Cancer

Nadine Abdel Hadi et al.

Summary: Cell metabolism in cancer cells is reprogrammed to meet their high energy and biosynthetic demands, leading to alterations in redox metabolism and accumulation of reactive oxygen species (ROS). Cancer cells adapt to high ROS levels, contributing to tumorigenesis, metastasis, therapy resistance, and relapse. Combining strategies to increase ROS production and inhibit antioxidant capacity is a promising approach for pancreatic cancer therapy.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Cell Biology

TP53INP1 exerts neuroprotection under ageing and Parkinson's disease-related stress condition

Emilie Dinh et al.

Summary: TP53INP1/dDOR plays a neuroprotective role in maintaining neuronal homeostasis, regulating autophagy and mitophagy in neurons. This has significant implications for neuroprotection and treatment of neurological disorders.

CELL DEATH & DISEASE (2021)

Article Oncology

Perioperative Predictors of Early Recurrence for Resectable and Borderline-Resectable Pancreatic Cancer

Masafumi Imamura et al.

Summary: Most patients with pancreatic ductal adenocarcinoma experience a recurrence after surgery, with preoperative and postoperative elevated CA19-9 levels, as well as a tumor size >3.0 cm, independently predicting early recurrence. Early recurrence is associated with more frequent liver metastasis, suggesting the presence of undetected micrometastases. New biomarkers are needed to accurately identify patients at risk for early recurrence.

CANCERS (2021)

Review Chemistry, Multidisciplinary

Mito-Bomb: Targeting Mitochondria for Cancer Therapy

Xiaolu Guo et al.

Summary: Traditional cancer therapies such as surgery, chemotherapy, and radiotherapy have limited effectiveness, while photodynamic therapy, photothermal therapy, and chemodynamic therapy have shown promising results in cancer treatment due to their high selectivity, minimal resistance, and minimal toxicity.

ADVANCED MATERIALS (2021)

Review Medicine, General & Internal

Advances in the management of pancreatic ductal adenocarcinoma

Grainne M. O'Kane et al.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2021)

Review Biochemistry & Molecular Biology

Overcoming chemoresistance by targeting reprogrammed metabolism: the Achilles' heel of pancreatic ductal adenocarcinoma

Abudureyimu Tuerhong et al.

Summary: Pancreatic ductal adenocarcinoma (PDAC) is characterized by late diagnosis and metabolic reprogramming related to glucose, lipid, and amino acid metabolism, which lead to resistance to chemotherapy. Targeting critical enzymes and/or transporters involved in metabolism may be a promising approach to overcome chemoresistance in PDAC.

CELLULAR AND MOLECULAR LIFE SCIENCES (2021)

Review Cell Biology

The biological underpinnings of therapeutic resistance in pancreatic cancer

Gregory L. Beatty et al.

Summary: Pancreatic ductal adenocarcinoma (PDAC) is a major cause of cancer-related mortality in the United States, with a low survival rate of 10% over 5 years. The disease demonstrates remarkable adaptability and resistance to therapeutic intervention, contributing to its poor prognosis. Recent advances in understanding the biological underpinnings of PDAC have revealed potential vulnerabilities that can be targeted for treatment.

GENES & DEVELOPMENT (2021)

Review Gastroenterology & Hepatology

Cell death in pancreatic cancer: from pathogenesis to therapy

Xin Chen et al.

Summary: Pancreatic cancer is a devastating gastrointestinal cancer with late diagnosis, limited treatment success and poor prognosis, primarily composed of pancreatic ductal adenocarcinoma (PDAC). The occurrence and progression of PDAC are influenced by various factors, and the exact impact of cell death on PDAC is not yet well described.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

Review Cell Biology

Autophagy is a major metabolic regulator involved in cancer therapy resistance

Laura Poillet-Perez et al.

Summary: Autophagy plays a crucial role in maintaining cellular homeostasis and metabolism in various diseases, including cancer. It can promote tumor growth through regulating cancer metabolism and resistance to therapy. Understanding the mechanisms of autophagy in tumor growth and resistance regulation is essential for advancing patient treatment strategies.

CELL REPORTS (2021)

Review Oncology

Genomic Heterogeneity of Pancreatic Ductal Adenocarcinoma and Its Clinical Impact

Maria Laura Gutierrez et al.

Summary: Pancreatic ductal adenocarcinoma (PDAC) remains a malignancy with limited therapeutic options due to its heterogeneous molecular profile. Research on genomic heterogeneity of PDAC has shown impacts on disease behavior and treatment, potentially leading to variable patient outcomes.

CANCERS (2021)

Review Oncology

Cancer metabolism: looking forward

Inmaculada Martinez-Reyes et al.

Summary: This Perspective discusses the main themes in cancer metabolism research, focusing on the relationship between tumour initiation and progression with metabolic reprogramming, as well as the importance of tumor microenvironment and metabolic regulation.

NATURE REVIEWS CANCER (2021)

Review Oncology

Autophagy in tumour immunity and therapy

Houjun Xia et al.

Summary: Autophagy plays a crucial role in cancer by influencing tumor progression, immune responses, and therapy outcomes. Modulating the autophagy pathway can enhance antitumor immune responses and improve treatment efficacy.

NATURE REVIEWS CANCER (2021)

Review Cell Biology

Autophagy and mitophagy in cancer metabolic remodelling

Fabio Ferro et al.

SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2020)

Review Oncology

From state-of-the-art treatments to novel therapies for advanced-stage pancreatic cancer

Christopher Nevala-Plagemann et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2020)

Article Oncology

Cancer statistics, 2020

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

Review Biochemistry & Molecular Biology

Metabolism of pancreatic cancer: paving the way to better anticancer strategies

Cheng Qin et al.

MOLECULAR CANCER (2020)

Article Genetics & Heredity

Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution

Michelle Chan-Seng-Yue et al.

NATURE GENETICS (2020)

Review Biochemistry & Molecular Biology

Redox Homeostasis and Metabolism in Cancer: A Complex Mechanism and Potential Targeted Therapeutics

Alia Ghoneum et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Multidisciplinary Sciences

Metabolic reprogramming and cancer progression

Brandon Faubert et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I

Keisuke Yamamoto et al.

NATURE (2020)

Review Biochemistry & Molecular Biology

Mitochondrial Metabolism in PDAC: From Better Knowledge to New Targeting Strategies

Gabriela Reyes-Castellanos et al.

BIOMEDICINES (2020)

Editorial Material Oncology

The Tumor Microenvironment of Pancreatic Cancer

Eva Karamitopoulou

CANCERS (2020)

Article Biochemistry & Molecular Biology

Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer

Kirsten L. Bryant et al.

NATURE MEDICINE (2019)

Article Biochemistry & Molecular Biology

Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers

Conan G. Kinsey et al.

NATURE MEDICINE (2019)

Review Gastroenterology & Hepatology

Molecular subtypes of pancreatic cancer

Eric A. Collisson et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)

Editorial Material Cell Biology

Blocking autophagy to starve pancreatic cancer

Kirsten L. Bryant et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)

Review Cell Biology

Role of tumor and host autophagy in cancer metabolism

Laura Poillet-Perez et al.

GENES & DEVELOPMENT (2019)

Review Cell Biology

Mechanisms and Implications of Metabolic Heterogeneity in Cancer

Jiyeon Kim et al.

CELL METABOLISM (2019)

Review Oncology

Targeting Autophagy in Cancer: Recent Advances and Future Directions

Ravi K. Amaravadi et al.

CANCER DISCOVERY (2019)

Article Gastroenterology & Hepatology

Levels of the Autophagy-Related 5 Protein Affect Progression and Metastasis of Pancreatic Tumors in Mice

Kivanc Goerguelue et al.

GASTROENTEROLOGY (2019)

Article Multidisciplinary Sciences

TP53INP1 deficiency maintains murine B lymphopoiesis in aged bone marrow through redox-controlled IL-7R/STAT5 signaling

Bochra Zidi et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Review Oncology

Systemic treatment of pancreatic cancer revisited

Michel Ducreux et al.

SEMINARS IN ONCOLOGY (2019)

Review Gastroenterology & Hepatology

Role of the tumor microenvironment in pancreatic cancer

Takashi Murakami et al.

ANNALS OF GASTROENTEROLOGICAL SURGERY (2019)

Review Biochemistry & Molecular Biology

Dual role of autophagy in hallmarks of cancer

Shikha Satendra Singh et al.

ONCOGENE (2018)

Review Oncology

Targeting Autophagy in Cancer

Angelique V. Onorati et al.

CANCER (2018)

Review Cell Biology

Cargo recognition and degradation by selective autophagy

Damian Gatica et al.

NATURE CELL BIOLOGY (2018)

Article Cell Biology

Metabolic Alterations in a Slow-Paced Model of Pancreatic Cancer-Induced Wasting

Elisabeth Wyart et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)

Article Gastroenterology & Hepatology

Stratification of Pancreatic Ductal Adenocarcinomas Based on Tumor and Microenvironment Features

Francesco Puleo et al.

GASTROENTEROLOGY (2018)

Article Multidisciplinary Sciences

Autophagy maintains tumour growth through circulating arginine

Laura Poillet-Perez et al.

NATURE (2018)

Article Medicine, General & Internal

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

T. Conroy et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Review Gastroenterology & Hepatology

Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes

Andrew McGuigan et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2018)

Article Geriatrics & Gerontology

Establishment and characterization of a novel murine model of pancreatic cancer cachexia

Katherine A. Michaelis et al.

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2017)

Article Gastroenterology & Hepatology

Acinar-to-Ductal Metaplasia Induced by Transforming Growth Factor Beta Facilitates KRASG12D-driven Pancreatic Tumorigenesis

Nicolas Chuvin et al.

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2017)

Review Biochemistry & Molecular Biology

Putting p53 in Context

Edward R. Kastenhuber et al.

Review Oncology

Targeting autophagy in cancer

Jean M. Mulcahy Levy et al.

NATURE REVIEWS CANCER (2017)

Review Biochemistry & Molecular Biology

Mitochondria and cancer chemoresistance

Flora Guerra et al.

BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2017)

Review Cell Biology

Autophagy and Tumor Metabolism

Alec C. Kimmelman et al.

CELL METABOLISM (2017)

Article Multidisciplinary Sciences

Macroautophagy is dispensable for growth of KRAS mutant tumors and chloroquine efficacy

Christina H. Eng et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Review Cell Biology

The Emerging Hallmarks of Cancer Metabolism

Natalya N. Pavlova et al.

CELL METABOLISM (2016)

Article Medicine, Research & Experimental

Pancreatic cancer microenvironment, to target or not to target?

Ryan M. Carr et al.

EMBO MOLECULAR MEDICINE (2016)

Article Multidisciplinary Sciences

Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion

Cristovao M. Sousa et al.

NATURE (2016)

Article Multidisciplinary Sciences

Genomic analyses identify molecular subtypes of pancreatic cancer

Peter Bailey et al.

NATURE (2016)

Review Multidisciplinary Sciences

Fundamentals of cancer metabolism

Ralph J. DeBerardinis et al.

SCIENCE ADVANCES (2016)

Article Multidisciplinary Sciences

Autophagy is induced in the skeletal muscle of cachectic cancer patients

Zaira Aversa et al.

SCIENTIFIC REPORTS (2016)

Review Biochemistry & Molecular Biology

The stress protein TP53INP1 plays a tumor suppressive role by regulating metabolic homeostasis

Houda Saadi et al.

BIOCHIMIE (2015)

Review Biochemistry & Molecular Biology

Autophagy in malignant transformation and cancer progression

Lorenzo Galluzzi et al.

EMBO JOURNAL (2015)

Article Medicine, Research & Experimental

Defects in mitophagy promote redox-driven metabolic syndrome in the absence of TP53INP1

Marion Seillier et al.

EMBO MOLECULAR MEDICINE (2015)

Article Biochemistry & Molecular Biology

Targeting mitochondria metabolism for cancer therapy

Samuel E. Weinberg et al.

NATURE CHEMICAL BIOLOGY (2015)

Article Multidisciplinary Sciences

Basal autophagy maintains pancreatic acinar cell homeostasis and protein synthesis and prevents ER stress

Laura Antonucci et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

Review Oncology

Pancreatic Cancer Metabolism: Breaking It Down to Build It Back Up

Rushika M. Perera et al.

CANCER DISCOVERY (2015)

Review Biochemistry & Molecular Biology

Interplay between ROS and autophagy in cancer cells, from tumor initiation to cancer therapy

Laura Poillet-Perez et al.

REDOX BIOLOGY (2015)

Article Multidisciplinary Sciences

Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function

Andrea Viale et al.

NATURE (2014)

Review Biochemistry & Molecular Biology

Autophagy-Mediated Tumor Promotion

Jessie Yanxiang Guo et al.

Article Gastroenterology & Hepatology

Mutant TP53 in Duodenal Samples of Pancreatic Juice From Patients With Pancreatic Cancer or High-Grade Dysplasia

Mitsuro Kanda et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)

Review Cell Biology

Exploiting the bad eating habits of Ras-driven cancers

Eileen White

GENES & DEVELOPMENT (2013)

Review Oncology

Histopathologic assessment of pancreatic cancer: Does one size fit all?

Michelle D. Reid et al.

JOURNAL OF SURGICAL ONCOLOGY (2013)

Article Multidisciplinary Sciences

p53 status determines the role of autophagy in pancreatic tumour development

Mathias T. Rosenfeldt et al.

NATURE (2013)

Review Biotechnology & Applied Microbiology

Modulation of oxidative stress as an anticancer strategy

Chiara Gorrini et al.

NATURE REVIEWS DRUG DISCOVERY (2013)

Article Multidisciplinary Sciences

Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids

Jurre J. Kamphorst et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Review Oncology

Deconvoluting the context-dependent role for autophagy in cancer

Eileen White

NATURE REVIEWS CANCER (2012)

Review Cell Biology

Autophagy in tumorigenesis and energy metabolism: friend by day, foe by night

Robin Mathew et al.

CURRENT OPINION IN GENETICS & DEVELOPMENT (2011)

Article Cell Biology

Pancreatic cancers require autophagy for tumor growth

Shenghong Yang et al.

GENES & DEVELOPMENT (2011)

Review Cell Biology

The dynamic nature of autophagy in cancer

Alec C. Kimmelman

GENES & DEVELOPMENT (2011)

Article Cell Biology

Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis

Jessie Yanxiang Guo et al.

GENES & DEVELOPMENT (2011)

Article Cell Biology

Autophagy facilitates glycolysis during Ras-mediated oncogenic transformation

Rebecca Lock et al.

MOLECULAR BIOLOGY OF THE CELL (2011)

Article Medicine, General & Internal

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

Thierry Conroy et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Review Oncology

Regulation of cancer cell metabolism

Rob A. Cairns et al.

NATURE REVIEWS CANCER (2011)

Article Cell Biology

Role of autophagy in suppression of inflammation and cancer

Eileen White et al.

CURRENT OPINION IN CELL BIOLOGY (2010)

Review Biochemistry & Molecular Biology

Autophagy in the pathogenesis of disease

Beth Levine et al.

Article Multidisciplinary Sciences

Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development

Meritxell Gironella et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)